1 min to read News Posted on March 3, 2023 Citigroup Maintains Buy on Eli Lilly, Lowers Price Target to $360 … – Benzinga Citigroup Maintains Buy on Eli Lilly, Lowers Price Target to $360 … benzinga Source: Citigroup Maintains Buy on Eli Lilly, Lowers Price Target to 0 … – Benzinga share tweet share Report: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPACSPACs: Are You Really Ready To Commit?By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawHow a SPAC works? Tags: SPACs